CDXNB

CARDIEXLTD DEF X OPT [CDXNB]

1 day chart

About CDXNB

Cardiex Limited is a global health technology company that focuses on hypertension, cardiovascular disease, and other vascular health disorders. The group manufacturing and R&D operations are in Sydney, Australia. The American subsidiary, ATCOR, is headquartered in Naperville, Illinois. Executive offices are in Newport Beach, California, and business development for Asian markets is in Shanghai.

Buy Australian shares starting with CDXNB. Invest today with a CHESS-sponsored investing platform!

Sector

CEO

Industry

Website

CardieX.com

Market Capitalisation

$20M

Price-earnings ratio

Dividend yield

0.00%

High today

Low today

Open price

52-week high

52-week low

Announcements

CDXNB FAQs

Can I buy CDXNB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CDXNB shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of CARDIEXLTD DEF X OPT [CDXNB]?

One share of CARDIEXLTD DEF X OPT [CDXNB] is valued at $0.00.

What is the ticker symbol for CARDIEXLTD DEF X OPT [CDXNB]?

The ticker symbol for CARDIEXLTD DEF X OPT [CDXNB] is CDXNB.

How do I buy CDXNB shares in Australia?

To buy CDXNB stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in CDXNB

What is the 52-week high for CARDIEXLTD DEF X OPT [CDXNB] stock?

The CARDIEXLTD DEF X OPT [CDXNB] 52-week high stock price is $NaN.

What is the 52-week low for CARDIEXLTD DEF X OPT [CDXNB] stock?

The CARDIEXLTD DEF X OPT [CDXNB] 52-week low stock price is $NaN.

What is the market capitalisation of CARDIEXLTD DEF X OPT [CDXNB] CDXNB?

As of 16/09/2023 CARDIEXLTD DEF X OPT [CDXNB] has a market cap of $20M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.